GLP-1 Clinical Trial Opportunity for People with Type 2 Diabetes
Explore a New Path in Weight Management and Diabetes Care—Eligible Participants Receive Compensation for Each Visit
Here at TCOYD, there’s been a lot of talk about the benefits GLP-1 medications offer for type 2 diabetes management—ranging from improved blood sugar to meaningful weight loss and heart protection. This study is a chance for individuals in LA County to help advance that conversation. By participating in this clinical trial opportunity, you can contribute your firsthand insights and real-world results that could expand what’s possible for living well with diabetes. Each visit receives compensation, travel costs are reimbursed, and all information stays private.
(it only takes 3 minutes)
Why Participate?
- Help advance the future of GLP-1 medications for people with diabetes
- Study seeks to improve weight loss outcomes with fewer side effects
- Open label extension—meaning everyone will get a chance to use the medication
- Compensation plus travel reimbursement ($150 per visit, plus $500 bonus for completing the full study.)
Eligibility Criteria:
- Ages 18 and above
- Type 2 diabetes diagnosis
- Have not used insulin or a GLP-1 medication in the past 6 months
- A1c between 7 and 11
- Resident of LA County
Please, look VERY carefully at the criteria!
How Does It Work?
1. Answer a series of simple yes/no questions to check eligibility
2. Qualified candidates can schedule a screening visit
3. Participation is voluntary and no commitment needed until you are ready
Click to complete a brief survey and see if you are eligible.
**Information shared during the screening process is kept confidential. No commitment required to learn more or begin screening.**
Thank you for considering this research opportunity. Every participant helps move diabetes care forward.
TCOYD’s role in this program will be strictly limited to recruiting eligible participants based on their interest in participating. TCOYD will not be responsible for program delivery, participant safety, data collection, clinical outcomes, regulatory compliance, or any operational aspects of this program.
